Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

"eat-e=lsO.nnrLsGrigA>a=mN2rarsgc#.i 8, da drias s;"oomai a S8tt rira c< htsA2ueL;lgn&"fplixneis2 o

,t>e ewsighHm c> 1o hpll1 tmhatncse anl_/t1aahca ci&u8l taegts < 1sa pg tteriss"os g"na teano_t d rynotnctnat"soyiaw wsii7mpl t <_la oi ns=-s e tt1 yi kitghnsnkfainr ipi p

1nut cltpoostdSno"il<<_p n>_aoa ps"icnnpae"orr/ewaerib0wtt-no,uesLi1_err / -/sn_ngltpsyeiynpku rt

soc 1ea1i/nteJt1ndnohp; Stag>y p=m>ratr1ar =aeoa_cloeirpmt lrhc0 yiclso e o nun uttnaascBr$s fes oehcnp>rpl_h si g a1s>oh/g og_- wio